Header Logo

Connection

RUTH L KATZ to Immunoconjugates

Back to Details
This is a "connection" page, showing publications RUTH L KATZ has written about Immunoconjugates.
RUTH L KATZ
Connection Strength
0.030
Immunoconjugates
  1. Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial. Clin Cancer Res. 1997 Sep; 3(9):1547-55.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.